Support.com, which provides cloud-based software and services, rose nearly 60% to $31.20, while biopharma NeuroMetrix climbed nearly 30% to $12.80.
Fed’s Powell, Apple, Peloton and VMware – 5 Things You Need to Know Friday
Retail investors talked about both companies on the stock trading platform Stocktwits.
“$ NURO the more volume we get, the more we drop.
“$SPRT New bag holders are being made!” stated another poster. “You don’t buy AFTER a stock is up 600%, you Idiots!”
Who Owns the Most AMC Shares?
Support.com announced in March that it is planning a reverse merger with privately held Greenidge Generation Holdings, which bills itself as “the first 100% carbon neutral Bitcoin transaction processor in the United States”.
Upon completion of the proposed transaction, Support.com will become a wholly owned subsidiary of Greenidge, the companies said.
Meanwhile, Zomedica (ZOOM) – Get Report stocks took a turn for the worse and started to slide despite interest in the veterinary health business from retailers on Reddit.
Morgan Stanley recently disclosed in a filing with the Securities and Exchange Commission that it had invested more than $1.6 million in Zomedica stock.
NeuroMetrix shares took off in July when the Food and Drug Administration issued a “Breakthrough Designation” to Quell’s biopharmaceutical device for treating fibromyalgia in adults.
Quell is an advanced, non-invasive nerve stimulation device covered by 18 U.S. utility patents, the company said.